Dergiler / Turkish archives of pediatrics (Online) / 2022 / Cilt: 57 - Sayı: 4

Cystinuria: An Overview of Diagnosis and Medical Management

Sayfa
377–384
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

In this article, we provide an overview of cystinuria with a special emphasis on medical treatment options including new agents such as alpha-lipoic acid.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Cystinuria is a genetic disorder that causes recurrent nephrolithiasis.
📊
Temel Bulgular & Veri:It is the most common type of monogenic stone disease accounting for 6%-8% of pediatric nephrolithiasis.
💡
Sonuç & Katkı:In this article, we provide an overview of cystinuria with a special emphasis on medical treatment options including new agents such as alpha-lipoic acid.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Özet

Cystinuria is a genetic disorder that causes recurrent nephrolithiasis. It is the most common type of monogenic stone disease accounting for 6%-8% of pediatric nephrolithiasis. Due to recurrent episodes of nephrolithiasis, it is associated with a very high prevalence of chronic kidney disease. Life-long medical treatment to reduce stone formation is critical in preventing chronic kidney disease and renal failure in cystinuria. In this article, we provide an overview of cystinuria with a special emphasis on medical treatment options including new agents such as alpha-lipoic acid.

🔖

Bu Makaleye Atıf Yap

SADIQ, S., ÇİL, O. (2022). Cystinuria: An Overview of Diagnosis and Medical Management. Turkish archives of pediatrics (Online), Cilt: 57 - Sayı: 4, 377–384. https://ajindex.com/articles/418302

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (15)

  1. Servais A, Thomas K, Dello Strologo L, et al. Cystinuria: clinical practice recommendation. Kidney Int. 2021
  2. 99(1):48-58. [CrossRef] 2. Leslie SW, Sajjad H, Nazzal L. Cystinuria. In: StatPearls [Internet]. Treasure Island, FL: StatPearls Publishing. 2022. Available at: https://ww w.ncb i.nlm.nih. gov/b ooks/ NBK47 0527/ 3. Sahota A, Tischfield JA, Goldfarb DS, Ward MD, Hu L. Cystinuria: genetic aspects, mouse models, and a new approach to therapy. Urolithiasis. 2019
  3. 47(1):57-66. [CrossRef] 4. Edvardsson VO, Goldfarb DS, Lieske JC, et al. Hereditary causes of kidney stones and chronic kidney disease. Pediatr Nephrol. 2013
  4. 28(10):1923-1942. [CrossRef] 5. Dello Strologo L, Pras E, Pontesilli C, et al. Comparison between SLC3A1 and SLC7A9 cystinuria patients and carriers: a need for a new classification. J Am Soc Nephrol. 2002
  5. 13(10):2547-2553. [CrossRef] 6. Chillarón J, Font-Llitjós M, Fort J, et al. Pathophysiology and treatment of cystinuria. Nat Rev Nephrol. 2010
  6. 6(7):424-434. [CrossRef] 7. Thier SO, Segal S, Fox M, Blair A, Rosenberg LE. Cystinuria: defective intestinal transport of dibasic Amion acids and cystine. J Clin Invest. 1965
  7. 44(3):442-448. [CrossRef] 8. Dent CE, Senior B. Studies on the treatment of cystinuria. Br J Urol. 1955
  8. 27(4):317-332. [CrossRef] 9. Pak CY, Fuller CJ. Assessment of cystine solubility in urine and of heterogeneous nucleation. J Urol. 1983
  9. 129(5):1066-1070. [CrossRef] 10. Andreassen KH, Pedersen KV, Osther SS, Jung HU, Lildal SK, Osther PJ. How should patients with cystine stone disease be evaluated and treated in the twenty-first century? Urolithiasis. 2016
  10. 44(1):65-76. [CrossRef] 11. Thomas K, Wong K, Withington J, Bultitude M, Doherty A. Cystinuria- a urologist's perspective. Nat Rev Urol. 2014
  11. 11(5): 270-277. [CrossRef] 12. Eggermann T, Venghaus A, Zerres K. Cystinuria: an inborn cause of urolithiasis. Orphanet J Rare Dis. 2012
  12. [CrossRef] 13. Rhodes HL, Yarram-Smith L, Rice SJ, et al. Clinical and genetic analysis of patients with cystinuria in the United Kingdom. Clin J Am Soc Nephrol. 2015
  13. 10(7):1235-1245. [CrossRef] 14. Barbosa M, Lopes A, Mota C, et al. Clinical, biochemical and molecular characterization of cystinuria in a cohort of 12 patients. Clin Genet. 2012
  14. 81(1):47-55. [CrossRef] 15. Régal L, Mårtensson E, Maystadt I, et al. PREPL deficiency: delineation of the phenotype and development of a functional blood assay. Genet Med. 2018
  15. 20(1):109-118. [CrossRef] 16. Eggermann T, Spengler S, Venghaus A, et